Antimicrobial Agents Practice Questions

Q: All of the following beta-lactam antibiotics possess antipseudomonal action, except:

Ceftriaxone. ***Ceftriaxone*** - **Ceftriaxone** is a third-generation cephalosporin that has broad-spectrum activity but **lacks reliable antipseudomonal activity**. - While effective against many **Gram-positive** and **Gram-negative bacteria**, it is not a recommended choice for treating **Pseudomonas aeruginosa infections**. *Piperacillin* - **Piperacillin** is an extended-spectrum penicillin (often combined with **tazobactam**) known for its potent activity against **Pseudomonas aeruginosa**. - It is frequently used in empirical treatment of severe infections where **pseudomonal coverage** is critical. *Ceftazidime* - **Ceftazidime** is a third-generation cephalosporin specifically developed to have strong activity against **Pseudomonas aeruginosa**. - It is a key antibiotic in the treatment of **pseudomonal infections**, particularly those affecting the **lungs** or **urinary tract**. *Cefoperazone* - **Cefoperazone** is a third-generation cephalosporin that demonstrates good antipseudomonal activity, especially when combined with a **beta-lactamase inhibitor** like **sulbactam**. - It is used in the treatment of various infections caused by **P. aeruginosa** and other **Gram-negative bacteria**.

Q: A patient diagnosed as having ventilator-associated pneumonia is on treatment with ceftriaxone and amikacin. Culture and sensitivity turned out to be positive for ESBL-producing Klebsiella infection. The most appropriate next action should be:

Change over to imipenem. ***Change over to imipenem*** - **ESBL-producing bacteria** are resistant to most beta-lactam antibiotics, including ceftriaxone. **Carbapenems** like imipenem are the drugs of choice for severe infections caused by ESBL producers. - Switching to imipenem provides **effective empirical coverage** given the updated culture and sensitivity results, ensuring appropriate treatment for the multidrug-resistant organism. *Continue same antibiotic but at higher dose* - ESBL-producing bacteria are **resistant to ceftriaxone**, making it ineffective even at higher doses. - Increasing the dose of an ineffective antibiotic delays appropriate treatment and contributes to **antibiotic resistance**. *Replace ceftriaxone with ceftazidime* - Ceftazidime is also a **third-generation cephalosporin** and is generally ineffective against ESBL-producing organisms. - Switching to another cephalosporin would represent a continuation of **inappropriate antibiotic therapy**. *Remove amikacin and add quinolone* - While quinolones may have activity against some Gram-negative bacteria, their effectiveness against **ESBL-producing Klebsiella** is variable and often compromised by resistance. - **Amikacin** (an aminoglycoside) is a broad-spectrum antibiotic often used in combination for severe infections, and its removal without clear resistance or adverse effects may reduce coverage, especially for synergistic effects against multidrug-resistant organisms.

Q: Rifampicin acts by inhibiting which of the following?

DNA Dependent RNA polymerase. ***DNA Dependent RNA polymerase*** - **Rifampicin** works by binding to the **beta-subunit** of bacterial **DNA-dependent RNA polymerase**, preventing the initiation of RNA synthesis [2]. - This action is **bactericidal** and is crucial for its effectiveness against **Mycobacterium tuberculosis** and other bacteria [2]. *RNA dependent DNA polymerase* - This enzyme is also known as **reverse transcriptase** and is found in **retroviruses**, not bacteria [1]. - While it is a target for antiretroviral drugs, it is **not the target of rifampicin** [1]. *Mycolic acid inhibition* - **Mycolic acid** synthesis is a target for antitubercular drugs like **isoniazid**, which inhibits **mycolic acid production**. - Rifampicin does **not directly inhibit mycolic acid synthesis** but rather interferes with RNA transcription. *Mycolic acid incorporation defects* - This mechanism is characteristic of drugs like **ethambutol**, which interferes with the **polymerization of arabinogalactan**, thus hindering the proper incorporation of mycolic acid into the cell wall. - Rifampicin's mechanism of action is **distinct** from interfering with mycolic acid incorporation.

Q: A patient with pulmonary tuberculosis, who is receiving anti-tuberculosis therapy consisting of rifampicin, isoniazid, ethambutol, and pyrazinamide, should be advised to take which of the following supplements?

Pyridoxine. ***Pyridoxine*** - **Isoniazid** in the anti-tuberculosis regimen can cause **peripheral neuropathy** by interfering with **pyridoxine (vitamin B6)** metabolism. - Supplementation with **pyridoxine** is advised to prevent this neurotoxic side effect, especially in patients at higher risk such as those with diabetes, malnutrition, or alcoholism. *Niacin* - **Niacin (vitamin B3)** deficiency can lead to **pellagra**, characterized by dermatitis, diarrhea, and dementia. - While important for general health, niacin supplementation is not specifically required to counteract side effects of standard anti-tuberculosis drugs. *Riboflavin* - **Riboflavin (vitamin B2)** is essential for various metabolic processes and cellular energy production. - There is no direct significant depletion or interference with riboflavin metabolism caused by the common anti-tuberculosis drugs. *Thiamine* - **Thiamine (vitamin B1)** deficiency can lead to **beriberi** and neurological symptoms, particularly in those with chronic alcoholism. - While thiamine is crucial for neurological function, antitubercular drugs do not specifically deplete or interfere with its metabolism to the extent of requiring routine supplementation.

Q: Hypothyroidism is caused by which of the following anti-tubercular drugs?

Ethionamide. ***Ethionamide*** - Ethionamide is a known **thiocarbamide derivative** that can inhibit thyroid hormone synthesis, leading to **hypothyroidism**. - It interferes with the binding of iodine to tyrosine residues within thyroglobulin, reducing the production of **T3 and T4 hormones**. *Streptomycin* - Streptomycin is an **aminoglycoside antibiotic** primarily associated with **ototoxicity** (vestibular and cochlear damage) and **nephrotoxicity**. - It does not have a well-documented association with thyroid dysfunction or hypothyroidism. *Thioacetazone* - Thioacetazone is a **second-line anti-tubercular drug** most commonly associated with severe skin reactions like **Stevens-Johnson syndrome (SJS)** and **toxic epidermal necrolysis (TEN)**. - While it can cause various side effects, hypothyroidism is not a typical or significant adverse effect. *Ethambutol* - Ethambutol's primary and most commonly recognized adverse effect is **ocular toxicity**, specifically **optic neuritis**, which can lead to red-green color blindness and decreased visual acuity. - It does not interfere with thyroid function or promote hypothyroidism.

Q: Common dose-dependent side effects of ethambutol include which of the following?

Optic neuritis. ***Optic neuritis*** - **Ethambutol** is known to cause dose-dependent **optic neuritis**, leading to decreased visual acuity and **red-green color blindness**. - This side effect is typically reversible if the drug is discontinued promptly, but delayed recognition can result in permanent visual impairment. *Red-orange urine* - **Red-orange discoloration of urine** is a characteristic side effect of **rifampin**, another antituberculosis drug, not ethambutol. - This side effect is benign and not indicative of organ dysfunction. *Nephrotoxicity* - **Nephrotoxicity** (kidney damage) is not a common or characteristic side effect of **ethambutol**. - Medications like **aminoglycosides** (e.g., gentamicin) and **NSAIDs** are more commonly associated with nephrotoxic effects. *Peripheral neuropathy* - **Peripheral neuropathy** is a common side effect associated with **isoniazid**, another antituberculosis medication. - It is often prevented or treated with concurrent administration of **pyridoxine (Vitamin B6)**.

Q: Which of the following drugs acts against Pseudomonas?

Piperacillin. ***Piperacillin*** - **Piperacillin** is an extended-spectrum penicillin often combined with **tazobactam** to protect against beta-lactamase degradation. - It has significant activity against **Pseudomonas aeruginosa**, making it a key antibiotic for severe **Gram-negative infections**. *Methicillin* - **Methicillin** is a narrow-spectrum penicillinase-resistant penicillin primarily used for **MSSA (methicillin-sensitive Staphylococcus aureus)** infections. - It lacks activity against **Pseudomonas aeruginosa** and is associated with significant **nephrotoxicity**. *Cloxacillin* - **Cloxacillin** is a narrow-spectrum, **beta-lactamase-resistant penicillin** used for **Staphylococcal infections**, similar to methicillin. - It is **ineffective** against **Pseudomonas aeruginosa**, which has a different cell wall structure and resistance mechanisms. *Nafcillin* - **Nafcillin** is another **penicillinase-resistant penicillin** used mainly for serious **Staphylococcal infections** like endocarditis. - It does not offer coverage against **Pseudomonas aeruginosa** and is often administered intravenously for severe infections.

Q: Bacitracin acts on:

Cell wall. ***Cell wall*** - **Bacitracin** inhibits bacterial **cell wall synthesis** by interfering with the dephosphorylation of the C55-isoprenyl pyrophosphate lipid carrier molecule. - This lipid carrier is essential for transporting **peptidoglycan** precursors across the bacterial membrane to the growing cell wall. *Cell membrane* - While bacitracin does target the synthesis pathway for the cell wall which is adjacent to the membrane, its direct action is not on the integrity or function of the **cell membrane** itself. - Drugs that act directly on the cell membrane typically disrupt its permeability, leading to leakage of cytoplasmic contents. *Nucleic acid* - **Nucleic acid** synthesis inhibitors (e.g., fluoroquinolones, rifampin) target DNA replication, transcription, or repair mechanisms. - Bacitracin does not interfere with the synthesis or function of bacterial **DNA** or **RNA**. *Ribosome* - **Ribosome** inhibitors (e.g., macrolides, tetracyclines) target bacterial protein synthesis, binding to either the 30S or 50S ribosomal subunit. - Bacitracin's mechanism of action is distinct from protein synthesis inhibition.

Q: Carbapenem with the maximum seizure risk is:

Imipenem. ***Imipenem*** - **Imipenem** is primarily associated with a higher risk of seizures due to its ability to inhibit **GABAergic neurotransmission** in the central nervous system. - This effect is dose-dependent and more pronounced in patients with **renal impairment** or pre-existing CNS disorders, where drug accumulation occurs. *Meropenem* - While meropenem can also cause seizures, its **GABA antagonistic effect** is less potent than imipenem, resulting in a lower incidence of this adverse event. - It is generally considered safer than imipenem for patients at risk of seizures. *Ertapenem* - Ertapenem has an even lower propensity for causing seizures compared to imipenem and meropenem. - It is often preferred in outpatient settings due to its **once-daily dosing** and favorable safety profile regarding CNS adverse effects. *Doripenem* - Doripenem also has a **low seizure potential**, similar to meropenem and ertapenem. - Its **pharmacokinetic profile** and CNS penetration differ, but it is not associated with the same high risk as imipenem.

Question 1

All of the following beta-lactam antibiotics possess antipseudomonal action, except:

Accepted Answer

Ceftriaxone

Answer

Ceftazidime

Answer

Cefoperazone

Answer

Piperacillin

Question 2

A patient diagnosed as having ventilator-associated pneumonia is on treatment with ceftriaxone and amikacin. Culture and sensitivity turned out to be positive for ESBL-producing Klebsiella infection. The most appropriate next action should be:

Accepted Answer

Change over to imipenem

Answer

Continue same antibiotic but at higher dose

Answer

Remove amikacin and add quinolone

Answer

Replace ceftriaxone with ceftazidime

Question 3

Rifampicin acts by inhibiting which of the following?

Accepted Answer

DNA Dependent RNA polymerase

Answer

RNA dependent DNA polymerase

Answer

Mycolic acid inhibition

Answer

Mycolic acid incorporation defects

Question 4

A patient with pulmonary tuberculosis, who is receiving anti-tuberculosis therapy consisting of rifampicin, isoniazid, ethambutol, and pyrazinamide, should be advised to take which of the following supplements?

Accepted Answer

Pyridoxine

Answer

Niacin

Answer

Riboflavin

Answer

Thiamine

Question 5

A 30-year-old female patient complains of a cough with sputum, and is a known case of tuberculosis who is currently taking rifampin for the same. All of the following are true about this drug except:

Accepted Answer

It binds with the alpha-subunit of prokaryotic RNA polymerase

Answer

It inhibits transcription

Answer

It binds with the beta-subunit of prokaryotic RNA polymerase

Answer

It is metabolized by CYP450 enzymes

Question 6

Hypothyroidism is caused by which of the following anti-tubercular drugs?

Accepted Answer

Ethionamide

Answer

Ethambutol

Answer

Thioacetazone

Answer

Streptomycin

Question 7

Common dose-dependent side effects of ethambutol include which of the following?

Accepted Answer

Optic neuritis

Answer

Peripheral neuropathy

Answer

Red-orange urine

Answer

Nephrotoxicity

Question 8

Which of the following drugs acts against Pseudomonas?

Accepted Answer

Piperacillin

Answer

Cloxacillin

Answer

Methicillin

Answer

Nafcillin

Question 9

Bacitracin acts on:

Accepted Answer

Cell wall

Answer

Cell membrane

Answer

Nucleic acid

Answer

Ribosome

Question 10

Carbapenem with the maximum seizure risk is:

Accepted Answer

Imipenem

Answer

Meropenem

Answer

Doripenem

Answer

Ertapenem

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?